Cargando…
Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)
BACKGROUND: Patients treated for a thoracic malignancy carry a significant risk of developing other lung lesions. Locoregional control of intrathoracic recurrences is challenging due to the impact of prior therapies on normal tissues. We examined the safety and efficacy of thoracic re-irradiation us...
Autores principales: | Reyngold, Marsha, Wu, Abraham J, McLane, Amanda, Zhang, Zhigang, Hsu, Meier, Stein, Nicholas F, Zhou, Ying, Ho, Alice Y, Rosenzweig, Kenneth E, Yorke, Ellen D, Rimner, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651392/ https://www.ncbi.nlm.nih.gov/pubmed/23617949 http://dx.doi.org/10.1186/1748-717X-8-99 |
Ejemplares similares
-
Potential for Interfraction Motion to Increase Esophageal Toxicity in Lung SBRT
por: Pham, Anthony Hoai-Nam, et al.
Publicado: (2017) -
PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT)
por: Lockney, Natalie A., et al.
Publicado: (2017) -
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
por: Barney, Brandon M, et al.
Publicado: (2012) -
Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations
por: Ricco, Anthony, et al.
Publicado: (2020) -
Re-irradiation in lung disease by SBRT: a retrospective, single institutional study
por: Caivano, Donatella, et al.
Publicado: (2018)